NOVARTIS

By June 19, 2019 Closed

An 8-week Multicenter, Randomized, Double-blind, Active Controlled, Parallel Group, and Forced Titration Study to Evaluate the Efficacy and Safety of Aliskiren / Amlodipine /HCTZ compared to Aliskiren / Amlodipine in US Minority Patients with Stage 2 Hypertension

Leave a Reply